| Investor Type | Firm |
| Industries | Other • Life Science |
| Stages | Early |
Merifin Capital Group is an experienced European private investment group with a history spanning over thirty years. They are headquartered in Brussels, Belgium, and operate with additional offices and executives in Geneva, New York, and London.
The firm focuses on managing a substantial investment portfolio across both traditional and alternative asset classes. Their investment strategy is versatile, incorporating early-stage venture capital along with late-stage, buy-outs, and turn-around investments.
Merifin Capital aims to harness the potential of various industries, with a particular acknowledgement of the significance of the life sciences sector. They endeavor to leverage their expertise to foster growth and innovation in the projects and companies they invest in. The firm’s philosophy underscores a commitment to driving success through active investment programs and strategic partnerships.
They position themselves not just as investors but as a support system for entrepreneurial endeavors, offering more than just financial investment but also contributing guidance and network advantages to empower businesses on their growth trajectory. Established on a bedrock of experience and a vast network, Merifin Capital positions themselves as a pivotal partner for companies aiming to achieve new milestones in their respective sectors. The firm extends its influence by engaging in sponsorship and providing insightful speeches, aiming to enrich the broader investment and business community.
Their website provides an overview of their investment philosophy, details on past and current investments, and information about their leadership team.







